Infrared Photobiomodulation in Humans With Epilepsy

Abroad (travel likely)Recruiting

Conditions

Drug Resistant Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

BIDMC, Boston, Massachusetts, United States
Contact: Study coordinator (Daniel Goldenholz, MD PhD) · daniel.goldenholz@bidmc.harvard.edu · 617-632-8930
Contact: Principal Investigator (Daniel Goldenholz, MD PhD)

Study leads

Daniel Goldenholz, MD PhD
Principal Investigator
Beth Israel Deaconess Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

Epilepsy · PET / MR · Synaptic Vesicle Proteins

Abroad (travel likely)Recruiting

Fuzhou, China

Surgery as a Treatment for Medically Intractable Epilepsy

Epilepsy · Epilepsy, Temporal Lobe · Partial Epilepsy

Abroad (travel likely)Recruiting

Bethesda, United States

Temporal Interference for Drug Resistant Epilepsy

Drug Resistant Epilepsy

Abroad (travel likely)Recruiting

Beijing, China

Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

Drug Resistant Epilepsy

Abroad (travel likely)Recruiting

South Brisbane, Australia · Melbourne, Australia